Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $12.37 billion. The enterprise value is $11.88 billion.
| Market Cap | 12.37B |
| Enterprise Value | 11.88B |
Important Dates
The last earnings date was Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 23.10 million shares outstanding. The number of shares has increased by 3.96% in one year.
| Current Share Class | 23.10M |
| Shares Outstanding | 23.10M |
| Shares Change (YoY) | +3.96% |
| Shares Change (QoQ) | -20.53% |
| Owned by Insiders (%) | 5.24% |
| Owned by Institutions (%) | 69.73% |
| Float | 13.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.63 |
| Forward PS | 6.90 |
| PB Ratio | 23.60 |
| P/TBV Ratio | 23.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.66.
| Current Ratio | 3.20 |
| Quick Ratio | 2.76 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.24 |
Financial Efficiency
Return on equity (ROE) is -53.31% and return on invested capital (ROIC) is -23.84%.
| Return on Equity (ROE) | -53.31% |
| Return on Assets (ROA) | -17.84% |
| Return on Invested Capital (ROIC) | -23.84% |
| Return on Capital Employed (ROCE) | -37.06% |
| Weighted Average Cost of Capital (WACC) | -1.04% |
| Revenue Per Employee | $1.40M |
| Profits Per Employee | -$355,295 |
| Employee Count | 915 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.82% in the last 52 weeks. The beta is -1.00, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -1.00 |
| 52-Week Price Change | +54.82% |
| 50-Day Moving Average | 515.65 |
| 200-Day Moving Average | 509.93 |
| Relative Strength Index (RSI) | 54.38 |
| Average Volume (20 Days) | 389,172 |
Short Selling Information
The latest short interest is 2.06 million, so 8.93% of the outstanding shares have been sold short.
| Short Interest | 2.06M |
| Short Previous Month | 3.53M |
| Short % of Shares Out | 8.93% |
| Short % of Float | 15.16% |
| Short Ratio (days to cover) | 4.80 |
Income Statement
In the last 12 months, MDGL had revenue of $1.28 billion and -$325.10 million in losses. Loss per share was -$14.22.
| Revenue | 1.28B |
| Gross Profit | 1.17B |
| Operating Income | -322.62M |
| Pretax Income | -325.10M |
| Net Income | -325.10M |
| EBITDA | -321.10M |
| EBIT | -322.62M |
| Loss Per Share | -$14.22 |
Balance Sheet
The company has $838.75 million in cash and $347.75 million in debt, with a net cash position of $491.00 million or $21.25 per share.
| Cash & Cash Equivalents | 838.75M |
| Total Debt | 347.75M |
| Net Cash | 491.00M |
| Net Cash Per Share | $21.25 |
| Equity (Book Value) | 523.72M |
| Book Value Per Share | 22.68 |
| Working Capital | 824.98M |
Cash Flow
In the last 12 months, operating cash flow was -$197.72 million and capital expenditures -$8.57 million, giving a free cash flow of -$206.29 million.
| Operating Cash Flow | -197.72M |
| Capital Expenditures | -8.57M |
| Depreciation & Amortization | 1.52M |
| Net Borrowing | 228.34M |
| Free Cash Flow | -206.29M |
| FCF Per Share | -$8.93 |
Margins
Gross margin is 91.48%, with operating and profit margins of -25.13% and -25.32%.
| Gross Margin | 91.48% |
| Operating Margin | -25.13% |
| Pretax Margin | -25.32% |
| Profit Margin | -25.32% |
| EBITDA Margin | -25.01% |
| EBIT Margin | -25.13% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.96% |
| Shareholder Yield | -3.96% |
| Earnings Yield | -2.63% |
| FCF Yield | -1.67% |
Analyst Forecast
The average price target for MDGL is $678.06, which is 26.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $678.06 |
| Price Target Difference | 26.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 45.01% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 7.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.29 |
| Piotroski F-Score | 2 |